0000950170-23-031844.txt : 20230705
0000950170-23-031844.hdr.sgml : 20230705
20230705205452
ACCESSION NUMBER: 0000950170-23-031844
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230705
DATE AS OF CHANGE: 20230705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mansbach Harry H
CENTRAL INDEX KEY: 0001300615
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39122
FILM NUMBER: 231071742
MAIL ADDRESS:
STREET 1: 15241 BARRANCA PKWY
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 89bio, Inc.
CENTRAL INDEX KEY: 0001785173
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831114349
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 432-9270
MAIL ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
ownership.xml
4
X0407
4
2023-06-30
0001785173
89bio, Inc.
ETNB
0001300615
Mansbach Harry H
C/O 89BIO, INC.
142 SANSOME STREET, 2ND FLOOR
SAN FRANCISCO
CA
94104
false
true
false
false
Chief Medical Officer
false
Common Stock
2023-06-30
4
A
false
8334
0
A
108456
D
Common Stock
2023-06-30
4
F
false
2882
18.95
D
105574
D
Represents settlement by the Issuer of performance-based restricted stock units ("RSUs") granted to the Reporting Person under the Company's Amended and Restated 2019 Equity Incentive Plan on February 17, 2022, which vested based on the Issuer's achievement of corporate performance objectives.
These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation.
/s/ Ryan A. Murr, as attorney-in-fact for Harry H. Mansbach
2023-07-05